Wachsberger P R, Burd R, Bhala A, Bobyock S B, Wahl M L, Owen C S, Rifat S B, Leeper D B
Department of Radiation Oncology, Kimmel Cancer Center and Thomas Jefferson University, Philadelphia, PA 19107, USA.
Int J Hyperthermia. 2003 Sep-Oct;19(5):507-19. doi: 10.1080/0265673031000078697.
Quercetin has been shown to act as a hyperthermia sensitizer by inhibiting the synthesis of heat shock protein 70 (HSP70) in a variety of tumour cell lines. It is most effective under conditions of low pH. This study was designed to test the hypothesis that quercetin suppresses thermotolerance development in cells adapted to growth at low pH and renders them as responsive as acutely acidified cells to hyperthermia-induced cytotoxicity. Chinese hamster ovarian carcinoma cells (OvCa) were exposed to 42 degrees C hyperthermia and/or quercetin (50-200 mm) at their growth pH of either 7.3 or 6.7 or after acute acidification from 7.3 to 6.7. Thermotolerance development was measured by colony survival. HSP70 synthesis and total protein synthesis were measured by radioactive precursor pulse labelling techniques. Quercetin, in a concentration-dependent manner, reduced the rate of total protein synthesis and increased cytotoxicity equally after acute acidification to pH 6.7 or growth at pH 6.7 at 37 degrees C, and to a greater extent than it did in cells at pH 7.3. At 42 degrees C, 100 mm quercetin inhibited total protein synthesis, HSP70 synthesis and thermotolerance development to a similar extent in cells grown at pH 6.7 or acutely acidified to pH 6.7. In contrast, quercetin reduced but did not completely inhibit HSP70 synthesis and thermotolerance development in cells grown and heated at pH 7.3. These results support the hypothesis that quercetin can specifically reduce thermotolerance development in tumour cells adapted to growth at pHe 6.7 so that they respond similarly to acutely acidified cells. Since many tumours are adapted to growth at low pH and may resist a wide variety of therapeutic modalities, inhibition of thermotolerance expression by quercetin may not only enhance the response to hyperthermia but the response to commonly used therapies such as chemotherapy and radiation.
槲皮素已被证明可通过抑制多种肿瘤细胞系中热休克蛋白70(HSP70)的合成来充当热疗增敏剂。在低pH条件下它最为有效。本研究旨在验证以下假设:槲皮素可抑制适应于在低pH下生长的细胞中热耐受的形成,并使它们对热疗诱导的细胞毒性的反应与急性酸化细胞一样敏感。中国仓鼠卵巢癌细胞(OvCa)在其生长pH值为7.3或6.7时,或从7.3急性酸化至6.7后,暴露于42℃热疗和/或槲皮素(50 - 200 mM)。通过集落存活来测定热耐受的形成。通过放射性前体脉冲标记技术测定HSP70合成和总蛋白合成。槲皮素以浓度依赖的方式降低总蛋白合成速率,并在急性酸化至pH 6.7后或在37℃下于pH 6.7生长时同等程度地增加细胞毒性,且比在pH 7.3的细胞中作用更大。在42℃时,100 mM槲皮素在pH 6.7生长或急性酸化至pH 6.7的细胞中,对总蛋白合成、HSP70合成和热耐受形成的抑制程度相似。相比之下,槲皮素在pH 7.3生长并加热的细胞中降低但未完全抑制HSP70合成和热耐受形成。这些结果支持以下假设:槲皮素可特异性降低适应于在pH 6.7生长的肿瘤细胞中热耐受的形成,从而使它们对急性酸化细胞的反应相似。由于许多肿瘤适应于在低pH下生长,并且可能抵抗多种治疗方式,槲皮素对热耐受表达的抑制可能不仅增强对热疗的反应,还增强对化疗和放疗等常用疗法的反应。